DXCM Q3 2019 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q3 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$396M+48.6% YoY

Gross Profit

$247M62.3% margin

Operating Income

$56M14.1% margin

Net Income

$46M11.6% margin

EPS (Diluted)

$0.13

QoQ Revenue Growth

+17.8%

Cash Flow

Operating Cash Flow

$95M

Free Cash Flow

$45M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$1.4B

Stockholders' Equity

$764M

Cash & Equivalents

$396M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$396M	$267M	+48.6%
Gross Profit	$247M	$169M	+46.4%
Operating Income	$56M	$14M	+302.9%
Net Income	$46M	$47M	-1.7%

Geographic Segments

UNITED STATES

$309M78%

Non-US

$88M22%